SGIOY (SGIOY) Stock Price & Analysis
SGIOY (SGIOY) fell 3.82% to USD 8.56 as of June 10, 2026 at 00:49 UTC, according to Nexqual real-time market data.
SGIOY last closed at USD 8.9; the session ranged USD 8.55–8.98 on volume of 23,701 shares. Market capitalization is $14.57B, with a 52-week range of USD 7.65–12 (PNK). Source: Nexqual, June 10, 2026 at 00:49 UTC.
Key Statistics (as of June 10, 2026 at 00:49 UTC)
| Price | USD 8.56 |
|---|---|
| Change | ▼ 3.82% (down) |
| Previous Close | USD 8.9 |
| Open | USD 8.98 |
| Day Range | USD 8.55 – 8.98 |
| 52-Week Range | USD 7.65 – 12 |
| Volume | 23,701 shares |
| Market Cap | $14.57B |
| Exchange | PNK |
Technical Analysis (SGIOY)
Nexqual's technical model rates SGIOY "SELL" based on 1 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 00:49 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 35.62 (neutral) |
| vs SMA50 | Below (USD 9.88) |
| MACD | -0.32 (negative) |
Analyst Ratings (SGIOY)
Wall Street analysts rate SGIOY "Strong Buy" based on 1 analysts, with a mean price target of USD 12.3 (range USD 12.3–12.3), per Nexqual as of June 10, 2026 at 00:49 UTC.
| Consensus Rating | Strong Buy |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 12.3 |
| High Target | USD 12.3 |
| Low Target | USD 12.3 |
| Buy / Hold / Sell | 1 / 0 / 0 |
Earnings (SGIOY)
| Revenue Estimate | $159.33B |
|---|
Source: Nexqual, June 10, 2026 at 00:49 UTC.
Financials & Fundamentals (SGIOY)
| Total Revenue | $499.68B |
|---|---|
| Revenue Growth (YoY) | +32.80% |
| Gross Margin | +83.50% |
| Operating Margin | -18.60% |
| Profit Margin | +41.06% |
| ROE | +13.51% |
| Debt / Equity | 40.59 |
| Current Ratio | 1.58 |
| Total Cash | $711.40B |
| Total Debt | $684.39B |
| Free Cash Flow | $-11.20B |
Source: Nexqual, June 10, 2026 at 00:49 UTC.
Financial Health Score (SGIOY)
Nexqual rates SGIOY's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 00:49 UTC.
| Growth | Critical — Revenue -11% YoY (annual), sharp decline |
|---|---|
| Profitability | Solid — Gross margin 83%, operating -19% |
| Balance Sheet | Solid — $711.4B cash vs $684.4B debt, net cash position |
| Cash Flow | Weak — FCF negative: -$11.2B, burning cash |
| Efficiency | Mixed — ROE 14%, ROA 3.8% |
Ownership (SGIOY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.02% |
| Shares Outstanding | 1.70B |
| Float | 1.70B |
Source: Nexqual, June 10, 2026 at 00:49 UTC.
Leadership (SGIOY)
SGIOY is led by Isao Teshirogi (age 66), CEO, President & Representative Director, per Nexqual as of June 10, 2026 at 00:49 UTC.
| CEO, President & Representative Director | Isao Teshirogi (age 66) |
|---|---|
| Vice President of Corporate Communications & Secretary Office | Yoshimasa Kyokawa |
| Vice President of General Marketing and Compliance Officer of Corporate GXP Compliance Office | Yoshihiro Furuya |
| Senior Exec. Officer, SVP of R & D Supervisory Unit and Pharma. Tech. Research Div. & Director | John Apeler Keller (age 61) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CHGCY | Chugai Pharmaceutical Co., Ltd. | USD 22.85 | ▼ 0.91% |
| OTSKY | Otsuka Holdings Co. Ltd. | USD 31.86 | ▼ 2.03% |
| SGIOF | Shionogi & Co. Ltd. | USD 17.68 | ▲ 10.5% |
| SSMXY | Sysmex Corp. | USD 9.04 | ▼ 1.53% |
| OPHLY | Ono Pharmaceutical Co., Ltd. | USD 4.56 | ▲ 0.22% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:49 UTC. This page is informational and not investment advice.